Several states are taking steps to address high prescription drug costs, with some considering or implementing policies such as affordability boards to help lower prices. The Trump administration has also been involved in efforts to reduce drug costs, including a reported deal with Pfizer. The specifics and outcomes of these initiatives are not yet clear, with some facing legal challenges.